Two Sigma Advisers’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-50
| Closed | -$198K | – | 2739 |
|
2022
Q3 | $198K | Sell |
50
-105
| -68% | -$416K | ﹤0.01% | 2205 |
|
2022
Q2 | $405K | Sell |
155
-139
| -47% | -$363K | ﹤0.01% | 2009 |
|
2022
Q1 | $944K | Sell |
294
-89
| -23% | -$286K | ﹤0.01% | 1669 |
|
2021
Q4 | $2.4M | Sell |
383
-78
| -17% | -$489K | 0.01% | 1101 |
|
2021
Q3 | $4.27M | Buy |
461
+210
| +84% | +$1.94M | 0.01% | 865 |
|
2021
Q2 | $2.54M | Buy |
+251
| New | +$2.54M | 0.01% | 1180 |
|
2021
Q1 | – | Sell |
-8
| Closed | -$49K | – | 2761 |
|
2020
Q4 | $49K | Sell |
8
-22
| -73% | -$135K | ﹤0.01% | 2322 |
|
2020
Q3 | $109K | Buy |
+30
| New | +$109K | ﹤0.01% | 2267 |
|